Investor Presentation Full Year 2017

Investor Presentation Full year 2017 Slide 74 Strong VictozaⓇ market leadership in Region Latin America Latin America GLP-1 market VictozaⓇ value market share in Latin America GLP-1 value in bDKK VictozaⓇ exenatide dulaglutide Share of total other GLP-1 value VictozaⓇ diabetes care market share exenatide dulaglutide other market 100% 1 0.6 8% 7% 0.5 CAGR value¹: 5.4% 80% 6% 75% 0.4 5% 60% 0.3 4% 40% - 3% 0.2 2% 20% 0.1 1% 0.0 0% 0% Nov 2012 Nov 2017 Nov 2012 23% 1% 1% Nov 2017 1 CAGR for 5-year period Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 value figures (DKK) changing diabetes® Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 value figures (DKK) novo nordisk

View entire presentation